Take Verve Therapeutics (NASDAQ: VERV), a small-cap, clinical-stage biotech. If Verve Therapeutics has any chance of soaring ...

Wall Street backed President Donald Trump because it was thinking about his first term promises rather than Trump 2.0. Then ...

The loans sat on banks’ books for two-and-a-half years until the election of Donald Trump rapidly changed the company’s ...

Heading into Meta's Q1 earnings, analysts are watching for key updates on AI initiatives, Instagram Reels, and growth in ad ...

A group of banks including Morgan Stanley, Bank of America, Barclays and Mitsubishi UFJ sold the final piece of debt tied to ...

Alphabet, Apple, Nvidia and the rest of the so-called “Magnificent Seven”—have lost a quarter of their value. Investors have ...

A group of banks including Morgan Stanley, Bank of America, Barclays and Mitsubishi UFJ sold the final piece of debt tied to ...

U.S. stocks drifted to a mixed, quiet finish ahead of a week with several potential flashpoints that could bring more sharp ...

Maguire, 69, spent decades diligently investing in her 401 (k) before she retired. Now the adviser wanted to take advantage ...

As tariffs loom over the sector, biotechs with U.S.-based manufacturing and intellectual property are soothing investor ...

But investors should brace for continued volatility as the market sits squarely in the middle of its 2025 trading range, said ...

NEW YORK — Big Tech stocks carried Wall Street Friday to the close of a winning, roller-coaster week, one that saw markets ...